ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, providing promising breakthroughs across numerous healthcare and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, extra trustworthy substitute for therapeutic use, especially